Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 9970-9984
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.9970
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.9970
Figure 1 Severe acute respiratory syndrome coronavirus 2 entry into angiotensin converting enzyme 2 is facilitated by transmembrane protease serine 2 induced activation of the S protein via its serine protease activity.
Inhibition of transmembrane protease serine 2 (TMPRSS2) may furnish an alternative strategy to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by blocking viral entry into host cells. ACE2: Angiotensin converting enzyme 2. Citation: Triposkiadis F, Xanthopoulos A, Giamouzis G, Boudoulas KD, Starling RC, Skoularigis J, Boudoulas H, Iliodromitis E. ACE2, the Counter-Regulatory Renin-Angiotensin System Axis and COVID-19 Severity. J Clin Med 2021; 10: 3885. Copyright ©The Author(s) 2021. Published by MDPI.
- Citation: Xanthopoulos A, Bourazana A, Giamouzis G, Skoularigki E, Dimos A, Zagouras A, Papamichalis M, Leventis I, Magouliotis DE, Triposkiadis F, Skoularigis J. COVID-19 and the heart. World J Clin Cases 2022; 10(28): 9970-9984
- URL: https://www.wjgnet.com/2307-8960/full/v10/i28/9970.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.9970